Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoarthritis.

B R Rubin1

  • 1Division of Rheumatology, Department of Internal Medicine, University of Texas Health Science Center at Fort Worth/Texas College of Osteopathic Medicine, 3500 Camp Bowie Blvd, Ft Worth, TX 76107-2970, USA. brubin@usc.unt.edu

The Journal of the American Osteopathic Association
|June 8, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.

Rheumatology (Oxford, England)·2006
Same author

Oral polymeric N-acetyl-D-glucosamine and osteoarthritis.

The Journal of the American Osteopathic Association·2001
Same author

Encephalitis in New York.

Lancet (London, England)·2000
Same author

Gastropathy induced by nonsteroidal anti-inflammatory drugs: prescribing patterns among geriatric practitioners.

The Journal of the American Osteopathic Association·1999
Same author

Specific cyclooxygenase-2 (COX-2) inhibitors.

The Journal of the American Osteopathic Association·1999
Same author

Alendronate useful in treating osteoporosis.

The Journal of the American Osteopathic Association·1997
Same journal

2020 AOA Research Abstracts and Poster Competition.

The Journal of the American Osteopathic Association·2020
Same journal

Communication Skills of Grandview/Southview Medical Center General Surgery Residents.

The Journal of the American Osteopathic Association·2020
Same journal

[PREPRINT] "Somebody Who Does Something Other Than Osteopathy".

The Journal of the American Osteopathic Association·2020
Same journal

Toward Resilience: Medical Students' Perception of Social Support.

The Journal of the American Osteopathic Association·2020
Same journal

Comparison of State Medical Licensing Board Disclosures Regarding Resident Performance for United States Allopathic, Osteopathic, and Foreign Medical Graduates.

The Journal of the American Osteopathic Association·2020
Same journal

Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.

The Journal of the American Osteopathic Association·2020
See all related articles

Arthritis is a common and disabling condition affecting more people. This article discusses new theories on arthritis risk factors and innovative treatment approaches.

Area of Science:

  • Rheumatology
  • Epidemiology

Background:

  • Arthritis is a prevalent and disabling condition.
  • Its prevalence is increasing within the general population.

Purpose of the Study:

  • To discuss emerging theories regarding arthritis risk factors.
  • To explore novel treatment paradigms for arthritis management.

Main Methods:

  • Literature review of recent studies on arthritis.
  • Analysis of current epidemiological data.
  • Synthesis of new theoretical frameworks for risk and treatment.

Main Results:

  • Identification of novel risk factors contributing to arthritis development.
  • Overview of innovative therapeutic strategies and their potential.

Related Experiment Videos

  • Discussion of the evolving understanding of arthritis pathogenesis.
  • Conclusions:

    • The understanding of arthritis risk factors is expanding.
    • New treatment paradigms offer promising avenues for patient care.
    • Continued research is essential for managing this widespread condition.